Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
about
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementHormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenGene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyMultigene prognostic tests in breast cancer: past, present, futureAre we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based modelsComparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyHOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease.Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.Breast Cancer Biomarkers: Utility in Clinical Practice.Cancer biomarker discovery: current status and future perspectives.Gene expression-based prognostic and predictive tools in breast cancer.Gene-Expression-Based Predictors for Breast Cancer.Biomarker assessment and molecular testing for prognostication in breast cancer.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.Endocrine Therapy for Early Breast Cancer: Updated Review.Genes and functions from breast cancer signatures.Spotlight on the utility of the Oncotype DX® breast cancer assay.Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.
P2860
Q27020973-8D46FF58-C25C-4EFA-BDCB-A38DDEDB2490Q28077637-74277ABA-2593-4A35-80DF-6277CBDD2B31Q34559124-B3FF92CB-AAD6-40C7-B900-0F62EECBC037Q35018599-394D96AA-61B9-441A-806A-E0E0BB153E6BQ35678667-DECF528E-24BD-436F-BFF4-6C0C4C41A9DAQ36151341-FBC6B429-3DE4-4772-A061-4C9885C37C14Q36903062-2CC30577-F5A5-4693-9A00-BB8121E23ACFQ37072929-86014B9F-0F8F-4D5B-A64A-627230DA02F0Q37214217-D7DA0E68-283E-449B-B4C4-0894DFD140ACQ37441159-6EF9DE13-3209-4C0D-83AF-CAC164FC57CAQ38187679-CC775816-1BEA-4D18-8FAA-E4D4A061B0B0Q38421414-AF2BC2FA-15E7-40F1-B1EA-82B8D56B33FBQ38555220-87902193-00E2-40E3-A8BF-62D1D3AECD59Q38696790-B4A4AC40-8B02-4513-A5B9-5B4410DC6EB2Q39187437-FEA0E611-0391-4A8F-B0A3-25C15ED09971Q45865884-5E5C17B7-4F1C-4E4E-AE94-85409DA59EB5Q47161589-FE77BE8E-EF87-4C54-8C04-F955EE6B2832Q52560707-55682FEA-215B-43E1-AB25-18AFD9C32DAAQ52728983-593C87F7-BDB0-4DAD-86EB-A5C53F532683Q54495437-0A0CC5EF-4964-4BA8-8B5F-714316666390
P2860
Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic utility of the brea ...... series of early breast cancer.
@ast
Prognostic utility of the brea ...... series of early breast cancer.
@en
type
label
Prognostic utility of the brea ...... series of early breast cancer.
@ast
Prognostic utility of the brea ...... series of early breast cancer.
@en
prefLabel
Prognostic utility of the brea ...... series of early breast cancer.
@ast
Prognostic utility of the brea ...... series of early breast cancer.
@en
P2093
P2860
P356
P1476
Prognostic utility of the brea ...... series of early breast cancer.
@en
P2093
Adam Brufsky
Hongying Li
Kristine Cooper
Mamatha Chivukula
Mark G Erlander
Nicole C Kesty
Rachel C Jankowitz
Xiao-Jun Ma
P2860
P2888
P356
10.1186/BCR3038
P577
2011-10-14T00:00:00Z
P5875
P6179
1022312855